VeraBIND Tau Assay

About Veravas

Veravas is an early-stage diagnostics company developing a proprietary sample preparation and biomarker enrichment platform called VeraBIND™. Its initial application is a blood-based test for the early detection of tau pathology in Alzheimer's disease, aiming to address a critical need for accessible, non-invasive diagnostics. The company's technology is positioned to enhance the accuracy of existing assays and enable the detection of low-abundance biomarkers across various diseases. Veravas operates as a private, likely pre-revenue entity, leveraging its platform to target the expansive neurodegenerative disease diagnostic market.

Therapeutic Areas